Byhealth300146.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Byhealth (300146.SZ) trades at a P/E of 24.60x, P/B of 1.47x, P/S of 2.17x, and a dividend yield of 4.72%.
Longitudinal percentile comparison: P/E sits at the 41st percentile over the trailing 10Y window (vs. 46th percentile over 3Y); P/B sits at the 4th percentile over the trailing 10Y window (vs. 12th percentile over 3Y); P/S sits at the 3rd percentile over the trailing 10Y window (vs. 10th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 48th percentile within its industry and the 34th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 5.38%, ranking at the 93rd percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 36.9 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower across the market than within its own industry — relatively cheaper next to the market as a whole. Of the 5.38% total shareholder yield, 4.72% is paid out as dividends and roughly 0.66% is implied to come from buybacks — both channels are meaningfully in play. Byhealth operates in the Food and Beverage sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300146 · SZSE: 300146 · 300146
Want the full picture on whether Byhealth (300146.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 24.60 | ||||||
| P/B (MRQ) | 1.47 | ||||||
| P/S (TTM) | 2.17 | ||||||
| Dividend Yield | 4.72% | ||||||
| Buyback + Div Yield | 5.38% |